Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.28 | 10.1083032491 | 2.77 | 3.39 | 2.73 | 69330 | 3.0858612 | CS |
| 4 | 0.24 | 8.5409252669 | 2.81 | 3.39 | 2.56 | 45785 | 2.92447555 | CS |
| 12 | -4.01 | -56.7988668555 | 7.06 | 7.76 | 2.56 | 99387 | 3.98583132 | CS |
| 26 | -1.012 | -24.913835549 | 4.062 | 23.8 | 2.56 | 1467346 | 11.14860222 | CS |
| 52 | -1.486 | -32.7601410935 | 4.536 | 23.8 | 2.56 | 814230 | 10.57534922 | CS |
| 156 | -371.35 | -99.1853632479 | 374.4 | 392.382 | 2.56 | 372478 | 31.03236436 | CS |
| 260 | -970.75 | -99.6867940029 | 973.8 | 1302.75 | 2.56 | 292981 | 188.19943175 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
